Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered human cancer models utilizing mammalian transgene expression.

S DiSean Kendall1, Stacey J Adam, Christopher M Counter

  • 1Department of Pharmacology and Molecular Cancer Biology, Duke University, Durham, North Carolina, USA.

Cell Cycle (Georgetown, Tex.)
|May 12, 2006
PubMed
Summary

New genetically-engineered human cancer models utilize only mammalian transgenes, offering a more precise tool for cancer biology research. These models overcome limitations of viral genetic elements, enhancing our understanding of cancer pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

Cancer discovery·2026
Same author

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same author

Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencing.

NPJ precision oncology·2026
Same author

Loss of inducible nitric oxide synthase promotes Kras/Pten-driven lung tumorigenesis.

Frontiers in cell and developmental biology·2026
Same author

KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.

Cancer research·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer models are crucial for research, with existing murine and human cell models having limitations.
  • Traditional methods for creating human cancer models often involved viral genetic elements, complicating pathway analysis.
  • Recent advancements allow human cell transformation into tumors using only mammalian transgenes.

Purpose of the Study:

  • To review and compare five recent genetically-engineered human cancer models.
  • To analyze the cell types transformed, transgenes expressed, and affected cancer pathways in these models.
  • To highlight the advantages of non-viral transgene-based human cancer models.

Main Methods:

  • Review of scientific literature reporting the development of five specific human cancer models.

Related Experiment Videos

  • Comparative analysis of the methodologies, genetic components, and cell origins of each model.
  • Examination of the downstream effects on cancer pathways for each model.

    • Main Results:

    • Successful transformation of primary human cells into tumors using only mammalian transgenes across five distinct models.
    • Variations in cell types utilized and specific transgenes expressed among the reviewed models.
    • Identification of affected cancer pathways, demonstrating the utility of these models for targeted research.

    Conclusions:

    • Genetically-engineered human cancer models using mammalian transgenes offer a valuable, genetically malleable research tool.
    • These models provide a more controlled environment for studying cancer biology compared to viral-based systems.
    • They complement existing cancer models and advance the understanding of cancer development and progression.